CN105999373B - 一种聚氨酯/小肠粘膜下层(pu/sis)双组份可注射水凝胶 - Google Patents
一种聚氨酯/小肠粘膜下层(pu/sis)双组份可注射水凝胶 Download PDFInfo
- Publication number
- CN105999373B CN105999373B CN201610380033.2A CN201610380033A CN105999373B CN 105999373 B CN105999373 B CN 105999373B CN 201610380033 A CN201610380033 A CN 201610380033A CN 105999373 B CN105999373 B CN 105999373B
- Authority
- CN
- China
- Prior art keywords
- acetic acid
- small intestine
- component
- neutralizer
- submucous layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000000813 small intestine Anatomy 0.000 title claims abstract description 53
- 239000007924 injection Substances 0.000 title claims abstract description 29
- 238000002347 injection Methods 0.000 title claims abstract description 29
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 title claims abstract description 25
- 239000004814 polyurethane Substances 0.000 title claims description 42
- 229920002635 polyurethane Polymers 0.000 title claims description 19
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 150
- 239000000843 powder Substances 0.000 claims abstract description 34
- 239000000839 emulsion Substances 0.000 claims abstract description 21
- 238000002360 preparation method Methods 0.000 claims abstract description 21
- 239000000017 hydrogel Substances 0.000 claims abstract description 15
- 238000003860 storage Methods 0.000 claims abstract description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical group CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 39
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 32
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- 239000004970 Chain extender Substances 0.000 claims description 24
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 19
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 18
- 239000000243 solution Substances 0.000 claims description 18
- 210000004400 mucous membrane Anatomy 0.000 claims description 16
- 238000006116 polymerization reaction Methods 0.000 claims description 14
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 12
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 12
- 239000007787 solid Substances 0.000 claims description 12
- 238000005406 washing Methods 0.000 claims description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 10
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical group OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 claims description 10
- 239000008367 deionised water Substances 0.000 claims description 9
- 229910021641 deionized water Inorganic materials 0.000 claims description 9
- 238000004108 freeze drying Methods 0.000 claims description 9
- 239000012948 isocyanate Substances 0.000 claims description 8
- 150000002513 isocyanates Chemical class 0.000 claims description 8
- 229920000642 polymer Polymers 0.000 claims description 8
- 238000000502 dialysis Methods 0.000 claims description 7
- 239000012535 impurity Substances 0.000 claims description 7
- 238000004140 cleaning Methods 0.000 claims description 6
- 238000004945 emulsification Methods 0.000 claims description 6
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 239000011259 mixed solution Substances 0.000 claims description 6
- 229920001610 polycaprolactone Polymers 0.000 claims description 6
- 235000019260 propionic acid Nutrition 0.000 claims description 6
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 6
- 102000057297 Pepsin A Human genes 0.000 claims description 5
- 108090000284 Pepsin A Proteins 0.000 claims description 5
- 102000004142 Trypsin Human genes 0.000 claims description 5
- 108090000631 Trypsin Proteins 0.000 claims description 5
- 239000003054 catalyst Substances 0.000 claims description 5
- AYLRODJJLADBOB-QMMMGPOBSA-N methyl (2s)-2,6-diisocyanatohexanoate Chemical compound COC(=O)[C@@H](N=C=O)CCCCN=C=O AYLRODJJLADBOB-QMMMGPOBSA-N 0.000 claims description 5
- 210000003205 muscle Anatomy 0.000 claims description 5
- 229940111202 pepsin Drugs 0.000 claims description 5
- 210000002826 placenta Anatomy 0.000 claims description 5
- 229920000909 polytetrahydrofuran Polymers 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 5
- 239000012588 trypsin Substances 0.000 claims description 5
- 239000005058 Isophorone diisocyanate Substances 0.000 claims description 4
- NIMLQBUJDJZYEJ-UHFFFAOYSA-N isophorone diisocyanate Chemical compound CC1(C)CC(N=C=O)CC(C)(CN=C=O)C1 NIMLQBUJDJZYEJ-UHFFFAOYSA-N 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 238000002791 soaking Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- KSBAEPSJVUENNK-UHFFFAOYSA-L tin(ii) 2-ethylhexanoate Chemical compound [Sn+2].CCCCC(CC)C([O-])=O.CCCCC(CC)C([O-])=O KSBAEPSJVUENNK-UHFFFAOYSA-L 0.000 claims description 3
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 claims description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 2
- UKLDJPRMSDWDSL-UHFFFAOYSA-L [dibutyl(dodecanoyloxy)stannyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[Sn](CCCC)(CCCC)OC(=O)CCCCCCCCCCC UKLDJPRMSDWDSL-UHFFFAOYSA-L 0.000 claims description 2
- 239000012975 dibutyltin dilaurate Substances 0.000 claims description 2
- 230000037314 wound repair Effects 0.000 claims description 2
- 239000000047 product Substances 0.000 claims 12
- 239000012467 final product Substances 0.000 claims 2
- 238000002156 mixing Methods 0.000 claims 2
- 239000004721 Polyphenylene oxide Substances 0.000 claims 1
- 229920000570 polyether Polymers 0.000 claims 1
- 229920005862 polyol Polymers 0.000 claims 1
- 150000003077 polyols Chemical class 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 17
- 230000006378 damage Effects 0.000 abstract description 9
- 230000002265 prevention Effects 0.000 abstract description 7
- 230000008520 organization Effects 0.000 abstract description 5
- 238000011065 in-situ storage Methods 0.000 abstract description 4
- 238000001879 gelation Methods 0.000 abstract description 3
- 230000001404 mediated effect Effects 0.000 abstract description 3
- 238000002513 implantation Methods 0.000 abstract description 2
- 208000025865 Ulcer Diseases 0.000 description 47
- 231100000397 ulcer Toxicity 0.000 description 47
- 241000282472 Canis lupus familiaris Species 0.000 description 39
- 229960000583 acetic acid Drugs 0.000 description 33
- 230000002980 postoperative effect Effects 0.000 description 29
- 208000027418 Wounds and injury Diseases 0.000 description 24
- 230000035876 healing Effects 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 12
- SUBDBMMJDZJVOS-DEOSSOPVSA-N esomeprazole Chemical group C([S@](=O)C1=NC2=CC=C(C=C2N1)OC)C1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-DEOSSOPVSA-N 0.000 description 12
- 239000000499 gel Substances 0.000 description 12
- 235000013305 food Nutrition 0.000 description 11
- 206010030201 Oesophageal ulcer Diseases 0.000 description 8
- 208000028299 esophageal disease Diseases 0.000 description 8
- 208000019064 esophageal ulcer Diseases 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 239000006210 lotion Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 210000004877 mucosa Anatomy 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 6
- 206010062575 Muscle contracture Diseases 0.000 description 5
- 208000006111 contracture Diseases 0.000 description 5
- 230000003902 lesion Effects 0.000 description 5
- 150000003384 small molecules Chemical group 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 206010002091 Anaesthesia Diseases 0.000 description 3
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 3
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 3
- 208000007107 Stomach Ulcer Diseases 0.000 description 3
- 230000037005 anaesthesia Effects 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 229960004770 esomeprazole Drugs 0.000 description 3
- 210000003238 esophagus Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 201000005917 gastric ulcer Diseases 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- PSGAAPLEWMOORI-PEINSRQWSA-N medroxyprogesterone acetate Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](OC(C)=O)(C(C)=O)CC[C@H]21 PSGAAPLEWMOORI-PEINSRQWSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 229920000333 poly(propyleneimine) Polymers 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 2
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 2
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 241000256856 Vespidae Species 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 235000005513 chalcones Nutrition 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000001839 endoscopy Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229940113433 esomeprazole 20 mg Drugs 0.000 description 2
- 201000005619 esophageal carcinoma Diseases 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 229960002725 isoflurane Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229940126409 proton pump inhibitor Drugs 0.000 description 2
- 239000000612 proton pump inhibitor Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000002271 resection Methods 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000003437 trachea Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 208000032544 Cicatrix Diseases 0.000 description 1
- 208000007217 Esophageal Stenosis Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030194 Oesophageal stenosis Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010051077 Post procedural haemorrhage Diseases 0.000 description 1
- 208000037486 Postoperative Hemorrhage Diseases 0.000 description 1
- 208000004550 Postoperative Pain Diseases 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 208000003167 cholangitis Diseases 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000002052 colonoscopy Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229960002887 deanol Drugs 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- -1 dihydroxymethyl Chemical group 0.000 description 1
- 239000012972 dimethylethanolamine Substances 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000012326 endoscopic mucosal resection Methods 0.000 description 1
- 238000002674 endoscopic surgery Methods 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 210000002599 gastric fundus Anatomy 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000010231 histologic analysis Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 235000020888 liquid diet Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000004632 polycaprolactone Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000009418 renovation Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000004876 tela submucosa Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000013585 weight reducing agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Botany (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Dispersion Chemistry (AREA)
Abstract
Description
Claims (12)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610380033.2A CN105999373B (zh) | 2016-05-30 | 2016-05-30 | 一种聚氨酯/小肠粘膜下层(pu/sis)双组份可注射水凝胶 |
PCT/CN2017/083577 WO2017206673A1 (zh) | 2016-05-30 | 2017-05-09 | 一种聚氨酯/小肠粘膜下层(pu/sis)双组份可注射水凝胶 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610380033.2A CN105999373B (zh) | 2016-05-30 | 2016-05-30 | 一种聚氨酯/小肠粘膜下层(pu/sis)双组份可注射水凝胶 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105999373A CN105999373A (zh) | 2016-10-12 |
CN105999373B true CN105999373B (zh) | 2019-08-16 |
Family
ID=57091899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610380033.2A Active CN105999373B (zh) | 2016-05-30 | 2016-05-30 | 一种聚氨酯/小肠粘膜下层(pu/sis)双组份可注射水凝胶 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN105999373B (zh) |
WO (1) | WO2017206673A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105999373B (zh) * | 2016-05-30 | 2019-08-16 | 拓睿美(北京)医疗科技有限公司 | 一种聚氨酯/小肠粘膜下层(pu/sis)双组份可注射水凝胶 |
CN110724245A (zh) * | 2018-07-17 | 2020-01-24 | 四川大学 | 可注射的聚氨酯及其制备方法 |
CN114377210B (zh) * | 2020-10-19 | 2024-02-20 | 四川大学华西医院 | 一种聚氨酯/小肠粘膜下层/聚吡咯复合材料及其制备方法和用途 |
CN115737924A (zh) * | 2021-09-03 | 2023-03-07 | 四川大学华西医院 | 一种可注射聚氨酯-小肠黏膜下层细胞微载体及其制备方法和用途 |
CN114848893B (zh) * | 2022-04-08 | 2024-05-24 | 大连医科大学 | 一种结合丝素蛋白的猪去细胞化小肠黏膜下层细胞外基质水凝胶及制备方法与应用 |
CN115282262B (zh) * | 2022-08-16 | 2024-07-12 | 四川大学华西医院 | 一种用于皮肤缺损治疗的组合物 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102743791A (zh) * | 2011-08-01 | 2012-10-24 | 四川大学华西医院 | 一种组织修复材料及其制备方法和用途 |
CN104189009A (zh) * | 2014-09-01 | 2014-12-10 | 四川大学华西医院 | 促血管化小肠粘膜下层温敏材料及其制备方法 |
CN104312140A (zh) * | 2014-10-22 | 2015-01-28 | 四川大学华西医院 | 一种聚氨酯/小肠粘膜下层复合材料及用途 |
CN104341608A (zh) * | 2014-10-22 | 2015-02-11 | 四川大学华西医院 | 聚氨酯/小肠粘膜下层复合材料的制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1926508A2 (en) * | 2005-07-27 | 2008-06-04 | Cook Incorporated | Implantable remodelable materials comprising magnetic material |
CN101185774B (zh) * | 2007-10-25 | 2011-06-08 | 王振军 | 一种医用生物相容性支架材料及其制备方法和应用 |
CN105999373B (zh) * | 2016-05-30 | 2019-08-16 | 拓睿美(北京)医疗科技有限公司 | 一种聚氨酯/小肠粘膜下层(pu/sis)双组份可注射水凝胶 |
-
2016
- 2016-05-30 CN CN201610380033.2A patent/CN105999373B/zh active Active
-
2017
- 2017-05-09 WO PCT/CN2017/083577 patent/WO2017206673A1/zh active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102743791A (zh) * | 2011-08-01 | 2012-10-24 | 四川大学华西医院 | 一种组织修复材料及其制备方法和用途 |
CN104189009A (zh) * | 2014-09-01 | 2014-12-10 | 四川大学华西医院 | 促血管化小肠粘膜下层温敏材料及其制备方法 |
CN104312140A (zh) * | 2014-10-22 | 2015-01-28 | 四川大学华西医院 | 一种聚氨酯/小肠粘膜下层复合材料及用途 |
CN104341608A (zh) * | 2014-10-22 | 2015-02-11 | 四川大学华西医院 | 聚氨酯/小肠粘膜下层复合材料的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105999373A (zh) | 2016-10-12 |
WO2017206673A1 (zh) | 2017-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105999373B (zh) | 一种聚氨酯/小肠粘膜下层(pu/sis)双组份可注射水凝胶 | |
AU2019203323B2 (en) | Method And Composition For Treating Inflammatory Bowel Disease Without Colectomy | |
CN109152737A (zh) | 结合基质的纳米囊泡及其用途 | |
US20240189349A1 (en) | Ecm hydrogel for treating esophageal inflammation | |
US20210093751A1 (en) | Method and composition for treating inflammatory bowel disease | |
WO2019053269A1 (en) | INJECTABLE HYBRID ALGINATE HYDROGELS AND USES THEREOF | |
JP2024023739A (ja) | 粘膜下流体クッションとしての細胞外マトリックス(ecm)ヒドロゲル | |
WO2020182139A1 (zh) | 消化道黏膜保护胶 | |
US20210268148A1 (en) | Use of a urinary bladder ecm hydrogel as an esophageal submucosal fluid cushion | |
KR102274661B1 (ko) | 생체적합성 필름 및 이의 제조방법 | |
CN115444993B (zh) | 细胞外基质(ecm)水凝胶作为食管粘膜下流体垫的用途 | |
CN104721810A (zh) | 类弹性蛋白多肽制备的软组织分离制剂及应用 | |
Li et al. | Surgical treatment of giant recurrent breast phyllodes tumor | |
Sun et al. | Comparison of clinical efficacy of different colon anastomosis methods in laparoscopic radical resection of colorectal cancer | |
RU2184495C2 (ru) | Способ лечения бронхиальной астмы | |
CN112972655A (zh) | 白细胞介素12在制备预防、缓解和/或治疗主动脉瘤药物中的应用 | |
CN118512473A (zh) | 一种自组装纳米酶的制备及其在心肌损伤修复中的应用 | |
CN107875106A (zh) | 一种祛疤贴及其制备方法 | |
Suriyarachchi et al. | Primary laparoscopic pull-through procedure for Hirschprung disease at a low resource setting: Experience and early results |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170505 Address after: 100089 Beijing city Haidian District Street factory wa No. 3 Danlong building block B room 1038 Applicant after: TOPREGMED (BEIJING) MEDICAL TECHNOLOGY Co.,Ltd. Address before: 610041 Wuhou District, Chengdu, China, No. Guoxue lane, No. 37 Applicant before: WEST CHINA HOSPITAL OF SICHUAN University |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20161012 Assignee: Albo Ruimei (Chengdu) Medical Technology Co.,Ltd. Assignor: TOPREGMED (BEIJING) MEDICAL TECHNOLOGY Co.,Ltd. Contract record no.: X2022510000048 Denomination of invention: A PU/SIS two-component injectable hydrogel Granted publication date: 20190816 License type: Common License Record date: 20221017 |
|
EE01 | Entry into force of recordation of patent licensing contract |